Clinical Significance of Tumor Markers in T2DM

被引：0
|
作者：
Luo, Yili
Liu, Lu
Chen, Ming
Xu, Lu
Zhang, Xiaoli
Gan, Dongmei
Sheng, Chunjun
Zhang, Manna
Bu, Le
Lin, Ziwei
Li, Hong
Qu, Shen
机构：
来源：
DIABETES | 2016年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1664-P
引用
收藏
页码：A433 / A433
页数：1
相关论文
共 50 条
  • [1] Blood-based markers for T2DM
    Tim Geach
    [J]. Nature Reviews Endocrinology, 2016, 12 (6) : 311 - 311
  • [2] Clinical inertia in management of T2DM
    Zafar, Azhar
    Davies, M.
    Azhar, A.
    Khunti, Kamlesh
    [J]. PRIMARY CARE DIABETES, 2010, 4 (04) : 203 - 207
  • [3] Significance of Hypoglycemia in T2DM Patients in Primary Care
    Lavernia, Frank
    Tomky, Donna M.
    Mcghee, Theresa A.
    Dex, Terry
    Dalal, Mehul
    Frimpter, Jeffrey
    Zhou, Wei
    Stewart, John
    Vlajnic, Aleksandra
    [J]. DIABETES, 2014, 63 : A562 - A563
  • [4] Safety of Dapagliflozin in Clinical Trials for T2DM
    Ptaszynska, Agata
    Johnsson, Kristina M.
    Apanovitch, Anne Marie
    Sugg, Jennifer E.
    Parikh, Shamik J.
    List, James F.
    [J]. DIABETES, 2012, 61 : A258 - A259
  • [5] Evaluation of some Inflammatory Markers Enzymes in T2DM Patients
    Mahmoud, Mohammed Wisam
    Khalid, Zaidan Noor
    Hiba, Al-Hadithe
    [J]. RESEARCH JOURNAL OF BIOTECHNOLOGY, 2024, 19 (08):
  • [6] Relevance and Clinical Significance of Serum Resistin Level in Obese T2DM Rhesus Monkey Models
    Qi, S. -d.
    He, Z. -l.
    Chen, Y.
    Ma, J.
    Yu, W. -h.
    Li, Y. -y.
    Yang, F. -m.
    Wang, J. -b.
    Chen, L. -x.
    Zhao, Y.
    Lu, S. -y.
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2015, 123 (08) : 508 - 513
  • [7] A simple clinical model that efficiently predicts T2DM
    不详
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 (10): : 675 - 675
  • [8] Benchmarking T2DM Treatment Effectiveness in Clinical Practice
    Testa, Marcia A.
    Turchin, Alexander
    Sosina, Olukayode A.
    Simonson, Donald C.
    [J]. DIABETES, 2015, 64 : A346 - A346
  • [9] Clinical inertia—a barrier to effective management of T2DM
    Julie A. Lovshin
    Bernard Zinman
    [J]. Nature Reviews Endocrinology, 2013, 9 : 635 - 636
  • [10] NAFLD with selective T2DM: An independent clinical entity?
    Qu, Shen
    Liu, Qing
    Li, Wenjun
    Chen, Shengguan
    Han, Yuqi
    Wang, Jiying
    Yang, Peng
    Cheng, Xiaoyun
    [J]. ENDOCRINE JOURNAL, 2010, 57 : S347 - S347
12345